Market Overview:
The global chemotherapy-induced oral mucositis market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, rising demand for better treatment options, and technological advancements in the field of oncology. Based on type, the global chemotherapy-induced oral mucositis market is segmented into ice chips (cryotherapy), preventive and supportive dental care, strong oral cleaning procedures, gels/rinses. The preventive and supportive dental care segment is expected to grow at a CAGR of 6.5% from 2018 to 2030 due to the growing awareness about the benefits of preventive dental care among patients undergoing chemotherapy. Based on application, the global chemotherapy-induced oral mucositis market is segmented into hospitals, oncology centres, research institutes, dental clinics and others. The hospitals segment accounted for majority share in 2017 owing to rising number of cancer patients across the globe seeking hospitalization for treatment purposes. However, with increasing demand for better treatment options coupled with technological advancements in diagnostic & therapeutic modalities such as radiation therapy & targeted therapy; Oncology Centres are projected witness highest growth rate during forecast period 2018 – 2030 .
Product Definition:
Chemotherapy-induced oral mucositis (CIM) is a common complication of cancer chemotherapy, affecting up to 80% of patients. It refers to the damage and inflammation of the mouth and throat that can occur as a side effect of certain chemotherapeutic agents. Symptoms include pain, redness, ulceration, bleeding, and difficulty swallowing or speaking. CIM can cause significant morbidity and mortality due to malnutrition, dehydration, infection, and airway obstruction.
Ice Chips(Cryotherapy):
Ice chips (cryotherapy) is a novel therapy that involves the use of extremely cold temperatures to treat cancer. The treatment aims at reducing pain and inflammation associated with cancer by limiting the amount of chemical reactions in the body. Ice chips work by causing harm to only those cells that are actively growing, while leaving non-cancerous cells unharmed. This allows for a reduction in harmful side effects without affecting healthy tissues or organs.
Preventive And Supportive Dental Care:
Preventive and supportive dental care is the most fundamental form of medical assistance provided to a patient. It helps in minimizing the risk of oral mucositis, which is an inflammation of oral cavity caused due to chemotherapy drugs or radiation therapy. The supportive treatment includes maintaining a healthy diet, maintaining hydration level in the body along with providing pain relief medications as per requirement.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The other applications include orthodontics, prosthodontics and periodontology. In recent years, there has been a rise in the adoption of preventive dental care and strong oral cleaning procedures for chemotherapy-induced oral mucositis as these procedures help prevent early stages of gingivitis and reduce the risk of periodontal disease development by more than 60%. This is expected to drive growth during the forecast period.
Oncology centers accounted for a significant share in terms of revenue generation as well as patient base due to increasing prevalence rates across various cancer types such as lung cancer, breast cancer, colorectal cancers etc., globally which is expected to further fuel product demand during the forecast period.
Regional Analysis:
North America dominated the global chemotherapy-induced oral mucositis market in 2017. This is due to an increase in the number of cancer patients, rise in awareness about chemotherapeutic drugs, and availability of supportive care products for treatment. Moreover, a high prevalence of dental disorders coupled with advanced healthcare infrastructure are some other factors contributing toward its large share.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing incidence rates of cancer and favorable government initiatives for research & development activities pertaining to CIMT treatment methodsologies that minimize toxic effects while delivering same therapeutic effect as conventional ones. The presence of less stringent regulations regarding marketing approval compared with developed regions also contributes toward regional growth prospects during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is expected to drive the demand for chemotherapy and, in turn, oral mucositis treatment.
- Growing awareness about oral mucositis: There is a growing awareness among people about oral mucositis and its treatment options. This is likely to boost the market growth in the coming years.
- Rising number of chemotherapeutic agents: The number of chemotherapeutic agents available for treating various types of cancers is rising rapidly. This will create opportunities for players operating in the chemotherapy-induced oral mucositis market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemotherapy-Induced Oral Mucositis Market Research Report
By Type
Ice Chips(Cryotherapy), Preventive And Supportive Dental Care, Strong Oral Cleaning Procedures, Gels/Rinses
By Application
Hospitals, Oncology Centres, Research Institutes, Dental Clinics, Others
By Companies
Izun Pharmaceuticals, Soleva Pharma, Aurora Bioscience, INNOVATION Pharma, Camurus AB, Monopar Therapeutics, Prothex Inc., Access Pharmaceutical Inc., Swedish Orphan Biovitrum AB, NeoMedLight
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Chemotherapy-Induced Oral Mucositis Market Report Segments:
The global Chemotherapy-Induced Oral Mucositis market is segmented on the basis of:
Types
Ice Chips(Cryotherapy), Preventive And Supportive Dental Care, Strong Oral Cleaning Procedures, Gels/Rinses
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Oncology Centres, Research Institutes, Dental Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Izun Pharmaceuticals
- Soleva Pharma
- Aurora Bioscience
- INNOVATION Pharma
- Camurus AB
- Monopar Therapeutics
- Prothex Inc.
- Access Pharmaceutical Inc.
- Swedish Orphan Biovitrum AB
- NeoMedLight
Highlights of The Chemotherapy-Induced Oral Mucositis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ice Chips(Cryotherapy)
- Preventive And Supportive Dental Care
- Strong Oral Cleaning Procedures
- Gels/Rinses
- By Application:
- Hospitals
- Oncology Centres
- Research Institutes
- Dental Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemotherapy-Induced Oral Mucositis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemotherapy-induced oral mucositis is a condition that results from the chemotherapy treatment of cancer. Chemotherapy can damage the cells in the mouth, which can lead to inflammation and pain.
Some of the key players operating in the chemotherapy-induced oral mucositis market are Izun Pharmaceuticals, Soleva Pharma, Aurora Bioscience, INNOVATION Pharma, Camurus AB, Monopar Therapeutics, Prothex Inc., Access Pharmaceutical Inc., Swedish Orphan Biovitrum AB, NeoMedLight.
The chemotherapy-induced oral mucositis market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chemotherapy-Induced Oral Mucositis Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Chemotherapy-Induced Oral Mucositis Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Chemotherapy-Induced Oral Mucositis Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Chemotherapy-Induced Oral Mucositis Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Chemotherapy-Induced Oral Mucositis Market Size & Forecast, 2018-2028 4.5.1 Chemotherapy-Induced Oral Mucositis Market Size and Y-o-Y Growth 4.5.2 Chemotherapy-Induced Oral Mucositis Market Absolute $ Opportunity
Chapter 5 Global Chemotherapy-Induced Oral Mucositis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
5.2.1 Ice Chips(Cryotherapy)
5.2.2 Preventive And Supportive Dental Care
5.2.3 Strong Oral Cleaning Procedures
5.2.4 Gels/Rinses
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chemotherapy-Induced Oral Mucositis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Oncology Centres
6.2.3 Research Institutes
6.2.4 Dental Clinics
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chemotherapy-Induced Oral Mucositis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chemotherapy-Induced Oral Mucositis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chemotherapy-Induced Oral Mucositis Analysis and Forecast
9.1 Introduction
9.2 North America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
9.6.1 Ice Chips(Cryotherapy)
9.6.2 Preventive And Supportive Dental Care
9.6.3 Strong Oral Cleaning Procedures
9.6.4 Gels/Rinses
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Oncology Centres
9.10.3 Research Institutes
9.10.4 Dental Clinics
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chemotherapy-Induced Oral Mucositis Analysis and Forecast
10.1 Introduction
10.2 Europe Chemotherapy-Induced Oral Mucositis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
10.6.1 Ice Chips(Cryotherapy)
10.6.2 Preventive And Supportive Dental Care
10.6.3 Strong Oral Cleaning Procedures
10.6.4 Gels/Rinses
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Oncology Centres
10.10.3 Research Institutes
10.10.4 Dental Clinics
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chemotherapy-Induced Oral Mucositis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chemotherapy-Induced Oral Mucositis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
11.6.1 Ice Chips(Cryotherapy)
11.6.2 Preventive And Supportive Dental Care
11.6.3 Strong Oral Cleaning Procedures
11.6.4 Gels/Rinses
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Oncology Centres
11.10.3 Research Institutes
11.10.4 Dental Clinics
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chemotherapy-Induced Oral Mucositis Analysis and Forecast
12.1 Introduction
12.2 Latin America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
12.6.1 Ice Chips(Cryotherapy)
12.6.2 Preventive And Supportive Dental Care
12.6.3 Strong Oral Cleaning Procedures
12.6.4 Gels/Rinses
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Oncology Centres
12.10.3 Research Institutes
12.10.4 Dental Clinics
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chemotherapy-Induced Oral Mucositis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chemotherapy-Induced Oral Mucositis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chemotherapy-Induced Oral Mucositis Market Size Forecast by Type
13.6.1 Ice Chips(Cryotherapy)
13.6.2 Preventive And Supportive Dental Care
13.6.3 Strong Oral Cleaning Procedures
13.6.4 Gels/Rinses
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chemotherapy-Induced Oral Mucositis Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Oncology Centres
13.10.3 Research Institutes
13.10.4 Dental Clinics
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chemotherapy-Induced Oral Mucositis Market: Competitive Dashboard
14.2 Global Chemotherapy-Induced Oral Mucositis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Izun Pharmaceuticals
14.3.2 Soleva Pharma
14.3.3 Aurora Bioscience
14.3.4 INNOVATION Pharma
14.3.5 Camurus AB
14.3.6 Monopar Therapeutics
14.3.7 Prothex Inc.
14.3.8 Access Pharmaceutical Inc.
14.3.9 Swedish Orphan Biovitrum AB
14.3.10 NeoMedLight